These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16991219)

  • 1. Telithromycin: severe hepatitis.
    Prescrire Int; 2006 Aug; 15(84):139. PubMed ID: 16991219
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hepatotoxicity of telithromycin.
    Bertino JS
    Ann Intern Med; 2006 Sep; 145(6):472; author reply 472. PubMed ID: 16983140
    [No Abstract]   [Full Text] [Related]  

  • 3. Telithromycin.
    Turner M; Corey GR; Abrutyn E
    Ann Intern Med; 2006 Mar; 144(6):447-8. PubMed ID: 16549859
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries for patients. Telithromycin: a possible cause of severe liver damage?
    Ann Intern Med; 2006 Mar; 144(6):I42. PubMed ID: 16481450
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute hepatitis attack after exposure to telithromycin.
    Onur O; Guneysel O; Denizbasi A; Celikel C
    Clin Ther; 2007 Aug; 29(8):1725-9. PubMed ID: 17919553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.
    Brinker AD; Wassel RT; Lyndly J; Serrano J; Avigan M; Lee WM; Seeff LB
    Hepatology; 2009 Jan; 49(1):250-7. PubMed ID: 19085949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review.
    Clay KD; Hanson JS; Pope SD; Rissmiller RW; Purdum PP; Banks PM
    Ann Intern Med; 2006 Mar; 144(6):415-20. PubMed ID: 16481451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated hepatic transaminases associated with telithromycin therapy: a case report and literature review.
    Bolesta S; Roslund BP
    Am J Health Syst Pharm; 2008 Jan; 65(1):37-41. PubMed ID: 18159037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telithromycin and the FDA: implications for the future.
    Shlaes DM; Moellering RC
    Lancet Infect Dis; 2008 Feb; 8(2):83-5. PubMed ID: 18222155
    [No Abstract]   [Full Text] [Related]  

  • 10. Telithromycin and acute liver failure.
    Graham DJ
    N Engl J Med; 2006 Nov; 355(21):2260-1. PubMed ID: 17124030
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms.
    Chen Y; Guo JJ; Healy DP; Lin X; Patel NC
    Ann Pharmacother; 2008 Dec; 42(12):1791-6. PubMed ID: 19033479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telithromycin: visual disorders.
    Prescrire Int; 2010 Apr; 19(106):71. PubMed ID: 20568490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin/telithromycin-induced rash in infectious mononucleosis.
    Wargo KA; McConnell V; Jennings M
    Ann Pharmacother; 2005 Sep; 39(9):1577. PubMed ID: 16046485
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective integration of medical and pharmacy claims to better protect patient safety--a long road yet to travel.
    Curtiss FR
    J Manag Care Pharm; 2007 Jun; 13(5):429-30. PubMed ID: 17605515
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketek--the FDA perspective.
    Soreth J; Cox E; Kweder S; Jenkins J; Galson S
    N Engl J Med; 2007 Apr; 356(16):1675-6. PubMed ID: 17442912
    [No Abstract]   [Full Text] [Related]  

  • 16. Telithromycin: review of adverse effects.
    Prescrire Int; 2014 Nov; 23(154):264-6. PubMed ID: 25954793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telithromycin use and spontaneous reports of hepatotoxicity.
    Dore DD; DiBello JR; Lapane KL
    Drug Saf; 2007; 30(8):697-703. PubMed ID: 17696582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telithromycin: visual disorders, myasthenia. Case fatalities: this macrolide has a negative risk-benefit balance; its use not justified.
    Prescrire Int; 2008 Apr; 17(94):66. PubMed ID: 18516818
    [No Abstract]   [Full Text] [Related]  

  • 19. Telithromycin-induced TEN: report of a case.
    Bédard MS; Gilbert M
    Arch Dermatol; 2007 Mar; 143(3):427-8. PubMed ID: 17372117
    [No Abstract]   [Full Text] [Related]  

  • 20. Telithromycin: another interacting macrolide.
    Prescrire Int; 2005 Oct; 14(79):179. PubMed ID: 16287219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.